Clinical Trial Update: Rapid Acting TMS for Suicide Ideation in Depression [NA]

View source ↗

Summary

The clinical trial NCT05100004 evaluating rapid-acting transcranial magnetic stimulation for suicide ideation in major depressive disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Stanford University | Conditions: Depressive Disorder, Major, Suicide | NA | Status: WITHDRAWN